News Sanofi escapes fine in EU mismarketing case Sanofi will not be fined for disparaging an influenza vaccine sold by rival CSL in a marketing campaign, according to the European Commission.
News New York declares measles outbreak a "disaster emergency" The governor of New York has said rising cases of measles constitute a statewide disaster emergency, as cases in neighbouring Pennsylvania pass 1,000.
News UK first country to launch CSL's trivalent flu shot Aujemflu CSL Seqirus' recently approved trivalent, cell-based influenza vaccine Aujemflu will be part of the UK's 2027/28 immunisation campaign.
News Bavarian Nordic has found its new CEO Six months after Paul Chaplin said he was stepping down as CEO of Bavarian Nordic, the Danish biopharma has named Tarja Stenvall to the role.
R&D Mosquitoes, malaria, and UK R&D viral disease vaccine invest... The UK must sustain investment in malaria R&D as it faces a “perfect storm” of challenges, including mosquito resistance to existing tools.
News GSK pushes 'next-generation' mRNA flu shot into phase 3 Buoyed by positive data in a phase 2 trial, GSK will start a phase 3 programme for an mRNA-based flu shot targeting both HA and NA flu antigens.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.